Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Express Scripts
Moodys
Boehringer Ingelheim
Colorcon

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Colloidal oatmeal

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Colloidal oatmeal?

Colloidal oatmeal is an investigational drug.

There have been 4 clinical trials for Colloidal oatmeal. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2014.

The most common disease conditions in clinical trials are Eczema, Dermatitis, Atopic, and Dermatitis. The leading clinical trial sponsors are Johnson & Johnson Consumer Inc. (J&JCI), Johnson & Johnson Consumer and Personal Products Worldwide, and Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.

There are forty-seven US patents protecting this investigational drug and three hundred and forty-seven international patents.

Recent Clinical Trials for Colloidal oatmeal
TitleSponsorPhase
Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With EczemaJohnson & Johnson Consumer Inc. (J&JCI)Phase 2
Test to Determine the Effectiveness of Moisturizing Balm Used on Babies With Dry, Itchy SkinJohnson & Johnson Consumer Inc. (J&JCI)N/A
A Test to Determine the Usefulness and Safety of a Cream Used on Babies With Dry Itchy SkinJohnson & Johnson Consumer and Personal Products WorldwidePhase 3

See all Colloidal oatmeal clinical trials

Clinical Trial Summary for Colloidal oatmeal

Top disease conditions for Colloidal oatmeal
Top clinical trial sponsors for Colloidal oatmeal

See all Colloidal oatmeal clinical trials

US Patents for Colloidal oatmeal

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Colloidal oatmeal   Start Trial Methods and compositions for treating skin Rodan & Fields, LLC (San Francisco, CA)   Start Trial
Colloidal oatmeal   Start Trial Bathing preparation for colloidal material Kao Corporation (Tokyo, JP) The Andrew Jergens Company (Cincinnati, OH)   Start Trial
Colloidal oatmeal   Start Trial Colloidal oatmeal solution applicator   Start Trial
Colloidal oatmeal   Start Trial Skin treatment composition   Start Trial
Colloidal oatmeal   Start Trial Bathing composition containing coated cationic polymer The Andrew Jergens Company (Cincinatti, OH) Kao Corporation (Tokyo, JP)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Colloidal oatmeal

Drugname Country Document Number Estimated Expiration Related US Patent
Colloidal oatmeal Canada 2059307 2011-01-31   Start Trial
Colloidal oatmeal Germany 69203471 2011-01-31   Start Trial
Colloidal oatmeal European Patent Office 0498272 2011-01-31   Start Trial
Colloidal oatmeal Spain 2077257 2011-01-31   Start Trial
Colloidal oatmeal Japan 2572693 2011-01-31   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Johnson and Johnson
McKinsey
Boehringer Ingelheim
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.